BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dwyer Z, Rudyk C, Thompson A, Farmer K, Fenner B, Fortin T, Derksen A, Sun H, Hayley S; CLINT (Canadian LRRK2 in inflammation team). Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration. Neurobiol Aging 2020;91:45-55. [PMID: 32247534 DOI: 10.1016/j.neurobiolaging.2020.02.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang M, Yi F, Wu J, Tang Y. The efficient generation of knockout microglia cells using a dual-sgRNA strategy by CRISPR/Cas9. Front Mol Neurosci 2022;15:1008827. [DOI: 10.3389/fnmol.2022.1008827] [Reference Citation Analysis]
2 Giachino C, Tirolo C, Caniglia S, Serapide MF, L’episcopo F, Bertoli F, Giuliano C, Mearelli M, Jakobi M, Schneiderhan-marra N, Deleidi M, Marchetti B. LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration.. [DOI: 10.1101/2022.09.01.505977] [Reference Citation Analysis]
3 Fu X, Wang J, Cai H, Jiang H, Jiang J, Chen H, Han S. Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment. JIR 2022;Volume 15:3797-814. [DOI: 10.2147/jir.s368291] [Reference Citation Analysis]
4 Zhang M, Li C, Ren J, Wang H, Yi F, Wu J, Tang Y. The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson’s Disease. Front Aging Neurosci 2022;14:909303. [DOI: 10.3389/fnagi.2022.909303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wahmane SA, Achbani A, Elmansouri N, Ferrera L, Elatiqi M, Raggabi A, Nejmeddine M, Belmouden A. Parkinson's disease: The prevalence of the LRRK2-G2019S mutation among the population of the South-West of Morocco. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101547] [Reference Citation Analysis]
6 Xu E, Boddu R, Abdelmotilib HA, Sokratian A, Kelly K, Liu Z, Bryant N, Chandra S, Carlisle SM, Lefkowitz EJ, Harms AS, Benveniste EN, Yacoubian TA, Volpicelli-Daley LA, Standaert DG, West AB. Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain. Mol Neurodegener 2022;17:7. [PMID: 35012605 DOI: 10.1186/s13024-021-00509-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
7 Cogo S, Ho FY, Tosoni E, Tomkins JE, Tessari I, Iannotta L, Montine TJ, Manzoni C, Lewis PA, Bubacco L, Chartier Harlin M, Taymans J, Kortholt A, Nichols J, Cendron L, Civiero L, Greggio E. The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation. Brain Research 2022. [DOI: 10.1016/j.brainres.2022.147781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Filipov NM. Pesticides Exposures and Parkinsonism: Experimental and Epidemiological Evidence of Association. Molecular and Integrative Toxicology 2022. [DOI: 10.1007/978-3-030-87451-3_6] [Reference Citation Analysis]
9 Iannotta L, Greggio E. LRRK2 signaling in neurodegeneration: two decades of progress. Essays Biochem 2021:EBC20210013. [PMID: 34897411 DOI: 10.1042/EBC20210013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Novello S, Mercatelli D, Albanese F, Domenicale C, Brugnoli A, D'Aversa E, Vantaggiato S, Dovero S, Murtaj V, Presotto L, Borgatti M, Shimshek DR, Bezard E, Moresco RM, Belloli S, Morari M. In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. Neurobiol Dis 2022;162:105579. [PMID: 34871735 DOI: 10.1016/j.nbd.2021.105579] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER. Preventing Parkinson's Disease: An Environmental Agenda. J Parkinsons Dis 2021. [PMID: 34719434 DOI: 10.3233/JPD-212922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Hayley S, Sun H. Neuroimmune multi-hit perspective of coronaviral infection. J Neuroinflammation 2021;18:231. [PMID: 34645457 DOI: 10.1186/s12974-021-02282-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Cai HY, Fu XX, Jiang H, Han S. Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson's disease. NPJ Parkinsons Dis 2021;7:91. [PMID: 34625569 DOI: 10.1038/s41531-021-00233-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fenner BM, Fenner ME, Prowse N, Hayley SP. LRRK2 and WAVE2 regulate microglial-transition through distinct morphological phenotypes to induce neurotoxicity in a novel two-hit in vitro model of neurodegeneration. J Cell Physiol 2021. [PMID: 34543438 DOI: 10.1002/jcp.30588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang Q, Cheng X, Wu W, Yang S, You H, Ye Z, Liu N, Chen X, Pan X. Age-related LRRK2 G2019S Mutation Impacts Microglial Dopaminergic Fiber Refinement and Synaptic Pruning Involved in Abnormal Behaviors. J Mol Neurosci 2021. [PMID: 34409578 DOI: 10.1007/s12031-021-01896-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 MacMahon Copas AN, McComish SF, Fletcher JM, Caldwell MA. The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes? Front Neurol 2021;12:666737. [PMID: 34122308 DOI: 10.3389/fneur.2021.666737] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 21.0] [Reference Citation Analysis]
17 Filippini A, Gennarelli M, Russo I. Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years. Biochem Soc Trans 2021;49:1375-84. [PMID: 33960369 DOI: 10.1042/BST20201092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Leem YH, Park JS, Park JE, Kim DY, Kim HS. Papaverine Exerts Neuroprotective Effect by Inhibiting NLRP3 Inflammasome Activation in an MPTP-Induced Microglial Priming Mouse Model Challenged with LPS. Biomol Ther (Seoul) 2021;29:295-302. [PMID: 33911050 DOI: 10.4062/biomolther.2021.039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
19 Franco R, Rivas-Santisteban R, Navarro G, Pinna A, Reyes-Resina I. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage. Int J Mol Sci 2021;22:4643. [PMID: 33924963 DOI: 10.3390/ijms22094643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Martínez-chacón G, Yakhine-diop SMS, González-polo RA, Bravo-san Pedro JM, Pizarro-estrella E, Niso-santano M, Fuentes JM. Links Between Paraquat and Parkinson’s Disease. Handbook of Neurotoxicity 2021. [DOI: 10.1007/978-3-030-71519-9_4-1] [Reference Citation Analysis]
21 von Linstow CU, Gan-Or Z, Brundin P. Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal. Transl Neurodegener 2020;9:39. [PMID: 33066808 DOI: 10.1186/s40035-020-00218-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
22 Xu E, Boddu R, Abdelmotilib HA, Kelly K, Sokratian A, Harms AS, Schonhoff AM, Bryant N, Harmsen IE, Schlossmacher MG, Chandra S, Krendelshchikova V, Liu Z, West AB. Pathologic α-Synuclein Species Activate LRRK2 in Pro-Inflammatory Monocyte and Macrophage Responses.. [DOI: 10.1101/2020.05.04.077065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]